A US company that on Tuesday was awarded a 35-million-dollar contract to develop an influenza vaccine using insect cell technology has produced a first batch against (A)H1N1 flu, company boss Dan Adams said.
A US company that on Tuesday was awarded a 35-million-dollar contract to develop an influenza vaccine using insect cell technology has produced a first batch against (A)H1N1 flu, company boss Dan Adams said.